Canagliflozin protects against hyperglycemia-induced cerebrovascular injury by preventing blood-brain barrier (BBB) disruption via AMPK/Sp1/adenosine A2A receptor
- Resource Type
- Article
- Source
- In
European Journal of Pharmacology 5 April 2024 968 - Subject
- Language
- ISSN
- 0014-2999